Paul A. Reilly

2.9k total citations · 1 hit paper
28 papers, 1.9k citations indexed

About

Paul A. Reilly is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Paul A. Reilly has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Paul A. Reilly's work include Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Paul A. Reilly is often cited by papers focused on Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Paul A. Reilly collaborates with scholars based in United States, Germany and Canada. Paul A. Reilly's co-authors include Janet B. McGill, Charles V. Pollack, Menno V. Huisman, Stephan Glund, Joachim Stangier, Frank W. Sellke, Pieter W. Kamphuisen, Jeffrey I. Weitz, Thorsten Steiner and Robert Dubiel and has published in prestigious journals such as New England Journal of Medicine, Circulation and Gastroenterology.

In The Last Decade

Paul A. Reilly

28 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Idarucizumab for Dabigatran Reversal

2015 981 citations Charles V. Pollack, Paul A. Reilly et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Paul A. Reilly

Since Specialization

Citations

This map shows the geographic impact of Paul A. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Reilly more than expected).

Fields of papers citing papers by Paul A. Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Reilly. The network helps show where Paul A. Reilly may publish in the future.

Co-authorship network of co-authors of Paul A. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Reilly. A scholar is included among the top collaborators of Paul A. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Reilly. Paul A. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study 2020 ·The American Journal of Medicine ·Samuel Z. Goldhaber, Walter Ageno, (unknown), Kok Han Chee, Sebastian Schellong, Daniel E. Singer, (unknown), Paul A. Reilly, (unknown), Wenbo Tang, Isabelle Voccia, Sam Schulman	8
2	Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding 2019 ·Circulation ·(unknown), Renato D. Lópes, James Aisenberg, Paul A. Reilly, Joanne van Ryn, Stephan Glund, Amelie Elsaesser, Frederikus A. Klok, Charles V. Pollack, Menno V. Huisman	29
3	Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis 2019 ·JAMA Neurology ·José M. Ferro, Jonathan M. Coutinho, Francesco Dentali, Adam Kobayashi, А. М. Алашеев, Patrícia Canhão, (unknown), Simon Nagel, (unknown), José Mário Roriz, (unknown), (unknown), Holger Huisman, Paul A. Reilly, Hans‐Christoph Diener, (unknown)	180
4	Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran 2015 ·Thrombosis and Haemostasis ·Paul A. Reilly, Richard A. Bernstein, Robert Dubiel, John W. Eikelboom, Stephan Glund, Menno V. Huisman, Elaine M. Hylek, CW Kam, Pieter W. Kamphuisen, (unknown), Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, Jeffrey I. Weitz, Charles V. Pollack	109
5	Idarucizumab for Dabigatran Reversal breakdown → 2015 ·New England Journal of Medicine ·Charles V. Pollack, Paul A. Reilly, John W. Eikelboom, Stephan Glund, Peter Verhamme, G. M. Bernstein, Robert Dubiel, Menno V. Huisman, Elaine M. Hylek, Pieter W. Kamphuisen, (unknown), Jerrold H. Levy, Frank W. Sellke, Joachim Stangier, Thorsten Steiner, Bushi Wang, CW Kam, Jeffrey I. Weitz	981
6	Dabigatran Does Not Prolong the QT Interval with Supratherapeutic Exposure: a Thorough QT Study in Healthy Subjects 2013 ·Clinical Drug Investigation ·Arne Ring, Karin Rathgen, Joachim Stangier, Paul A. Reilly, Andreas Clemens, Jeffrey Friedman	6
7	Oral bioavailability of dabigatran etexilate (Pradaxa^®) after co‐medication with verapamil in healthy subjects 2012 ·British Journal of Clinical Pharmacology ·Sebastian Härtter, Regina Sennewald, Gerhard Nehmiz, Paul A. Reilly	135
8	An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials 2005 ·Drug Information Journal ·Per Johanson, Paul W. Armstrong, Alejandro Barbagelata, Bernard Chaitman, Peter Clemmensen, Mikael Dellborg, J. French, Shaun G. Goodman, Cindy L. Green, Mitchell W. Krucoff, Anatoly Langer, Olle Pahlm, Paul A. Reilly, Galen S. Wagner	1
9	Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial 2001 ·Clinical Therapeutics ·Janet B. McGill, Paul A. Reilly	108
10	Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension 2001 ·Clinical Cardiology ·Janet B. McGill, Paul A. Reilly	46
11	How should we manage fibromyalgia? 1999 ·Annals of the Rheumatic Diseases ·Paul A. Reilly	13
12	Clinical Experience With Transdermal Clonidine in African-American and Hispanic-American Patients With Hypertension 1999 ·American Journal of Therapeutics ·Virgil C. Dias, Beatriz Tendler, Suzanne Oparil, Paul A. Reilly, (unknown), William B. White	19
13	Approaches to RSI in the United Kingdom 1995 ·Journal of Musculoskeletal Pain ·Paul A. Reilly	2
14	Fibromyalgia and chronic fatigue syndrome 1990 ·Current Opinion in Rheumatology ·Paul A. Reilly, Geoffrey Littlejohn	9
15	Pregnancy outcome and autoantibodies in connective tissue disease. 1989 ·The Journal of Rheumatology ·NJ McHugh, Paul A. Reilly, (unknown)	44
16	THERAPEUTIC INTERVENTION IN RHEUMATOID ARTHRITIS: A CASE-CONTROLLED COMPARISON OF SERONEGATIVE AND SEROPOSITIVE DISEASE 1988 ·Lara D. Veeken ·Paul A. Reilly, (unknown), A Cãlin	6
17	Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica 1987 ·Clinical Rheumatology ·Paul A. Reilly, Peter J. Maddison	1
18	The occurrence of two hepatic microsomal sites for amobarbital hydroxylation 1983 ·Canadian Journal of Physiology and Pharmacology ·Paul A. Reilly, Boxin Tang, (unknown), W. Kalow	4
19	Dipyridamole disposition after chronic administration: Effect of aspirin 1983 ·Thrombosis Research ·Jack Rosenfeld, Michael R. Buchanan, Paul A. Reilly, Alexander G.G. Turpie	6
20	Noninvasive echo-Doppler duplex measurements of common femoral artery blood flow variables during supine exercise and post-occlusive reactive hyperemia. 1982 ·PubMed ·Melissa Sutton, Ernest R. Greene, Elaine C. Johnson, Paul A. Reilly	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact